| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10036751 | HBV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
| TVIS10050050 | HBV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
| TVIS30035474 | HIV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
| TVIS20046672 | HPV | ENSG00000136160.17 | protein_coding | EDNRB | No | No | 1910 | P24530 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | EDNRB |
|---|---|
| DrugBank ID | DB00559 |
| Drug Name | Bosentan |
| Target ID | BE0000043 |
| UniProt ID | P24530 |
| Regulation Type | antagonist |
| PubMed IDs | 11752352; 7921608; 16335785; 9806221; 7858879; 15629255 |
| Citations | Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Gardiner SM, Kemp PA, March JE, Bennett T: Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br J Pharmacol. 1994 Jul;112(3):823-30.@@Gupta SK, Saxena A, Singh U, Arya DS: Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion. Mol Cell Biochem. 2005 Jul;275(1-2):67-74.@@Marano G, Palazzesi S, Bernucci P, Grigioni M, Formigari R, Ballerini L: ET(A)/ET(B) receptor antagonist bosentan inhibits neointimal development in collared carotid arteries of rabbits. Life Sci. 1998;63(18):PL259-66.@@Richard V, Kaeffer N, Hogie M, Tron C, Blanc T, Thuillez C: Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br J Pharmacol. 1994 Nov;113(3):869-76.@@Said SA, Ammar el SM, Suddek GM: Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes. Pharmacol Res. 2005 Feb;51(2):107-15. |
| Groups | Approved; Investigational |
| Direct Classification | Bipyrimidines and oligopyrimidines |
| SMILES | COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1 |
| Pathways | |
| PharmGKB | PA10034 |
| ChEMBL | CHEMBL957 |
